SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SanBio Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2023 | -18.86M |
| July 31, 2022 | -29.91M |
| July 31, 2021 | -31.63M |
| July 31, 2020 | -23.33M |
| July 31, 2019 | -25.65M |
| Date | Value |
|---|---|
| July 31, 2018 | -19.36M |
| July 31, 2017 | -17.32M |
| July 31, 2016 | -5.968M |
| July 31, 2015 | -5.752M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-31.63M
Minimum
Jul 2021
-18.86M
Maximum
Jul 2023
-25.88M
Average
-25.65M
Median
Jul 2019
Cash from Operations (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.999B |
| Nxera Pharma Co Ltd | -14.86M |
| PeptiDream Inc | -12.96M |
| Healios KK | -4.144M |
| AnGes Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -41.43% |